Intratumoral heterogeneity may be responsible for chemotherapy resistance in patients with small cell lung cancer
Small cell lung cancer (SCLC) accounts for 14% of all lung cancers and is often…
Browsing: small cell lung cancer
Summary report on small cell lung cancer research points to progress and challenges
In 2017, a group of lung cancer experts posed the question: “Can recent advances in…
Tasmanian devil research could help tackle immunotherapy resistance
A cluster of interacting proteins that are active in both human cancers and Tasmanian devil…
AACR 2019: Two KEYNOTE trials show pembrolizumab benefit for advanced SCLC
The anti-PD-1 monoclonal antibody pembrolizumab (Keytruda) showed promising antitumour activity with durable responses in patients…
Prophylactic cranial irradiation: Improvements for advanced NSCLC
Prophylactic cranial irradiation (PCI), a technique used to prevent the clinical development of brain metastases,…
Small cell lung cancer may respond to combination of immunotherapy and DNA damage repair inhibitors
Researchers have discovered that a combination of immune checkpoint blockade and targeted therapies that block…
Concurrent chemo-radiotherapy should be a treatment option for elderly patients with LS-S
Elderly patients with showed similar survival and toxicity compared to their younger counterparts when treated…
Tiny nanoparticles offer significant potential in detecting and treating disease
Tiny nanoparticles offer significant potential in detecting and treating disease, according to a new review.…
Research holds promise for personalised lung cancer treatments
New research from scientists at Huntsman Cancer Institute (HCI) at the University of Utah uncovered…
Aggressive lung cancer’s aggressiveness may be its Achilles’ heel
Researchers at the University of Virginia School of Medicine have discovered a flaw in the…